S phenoid ridge meningiomas constitute ~ 18% of all intracranial meningiomas. 48 In 1938, they were classified by Cushing and Eisenhardt 10 into outer (pterional), middle (alar), and inner (deep, clinoidal) lesions according to their site of dural attachment on the lesser sphenoid wing. Meningiomas in the ACP account for less than half of sphenoid ridge meningiomas. They were first described in 1910 by Frotscher and Becker 18 as an autopsy finding in a 72-year-old man.
S phenoid ridge meningiomas constitute ~ 18% of all intracranial meningiomas. 48 In 1938, they were classified by Cushing and Eisenhardt 10 into outer (pterional), middle (alar), and inner (deep, clinoidal) lesions according to their site of dural attachment on the lesser sphenoid wing. Meningiomas in the ACP account for less than half of sphenoid ridge meningiomas. They were first described in 1910 by Frotscher and Becker 18 as an autopsy finding in a 72-year-old man. 10, 41 In the past 3 decades, surgical morbidity and mortality associated with these lesions have been significantly reduced. Nonetheless, even in the microsurgical era, ACP meningiomas are still reported to have the highest surgical complication and recurrence rate (next to clival meningiomas) among all intracranial meningiomas. 2, 37 From a surgical perspective, there are 2 main controversial issues in regard to optimal treatment of these lesions: the surgical approach most suitable for these tumors and the extent of bone resection required, and the best management strategy for the intracavernous tumor portion. The purpose of the present study was to evaluate long-term follow-up results in a consecutive series of patients treated microsurgically for an ACP meningioma. In our analysis, we particularly concentrated on the longterm ophthalmological outcome and tumor recurrence and progression rates.
Anterior clinoidal meningiomas: functional outcome after microsurgical resection in a consecutive series of 106 patients
Methods

Patient Population
We retrospectively analyzed the clinical records, neuroimaging studies, and long-term follow-up data in a consecutive series of 106 patients harboring ACP meningiomas. Patients included in this study were treated microsurgically between January 1987 and June 2005 at 2 neurosurgical departments (University Hospital of Essen, and University Hospital of Frankfurt/Main). All tumors were confirmed by histological examination, and only lesions with a main dural origin on the ACP, adjacent part of the medial sphenoid ridge, and lateral CS wall as established by preoperative MR imaging and during surgery were included in the present analysis. 4, 6 Neuroradiological Studies All patients underwent preoperative CT scanning. In 104 patients, multiplanar contrast-enhanced T1-weighted MR images were also obtained. A high-resolution bonewindow CT scan of the anterior and middle cranial base was obtained in 87 patients to assess for tumor-induced bone changes. Preoperative angiography was conducted in 43 patients and superselective embolization (Contour PVA particles; Boston Scientific Corp.) of tumor feeding arteries originating from the external carotid artery (usually the MMA) was performed in 13 patients (12.3%) before surgery.
Surgical Approach
Our treatment strategy encompassed complete microsurgical resection of the extracavernous tumor with particular emphasis on optic nerve decompression. This included resection or bipolar coagulation of the dural tumor matrix and removal of bone hyperostosis as disclosed on the preoperative bone-window CT scan. Removal of the tumor and its extensions ( Fig. 1 ) was accomplished in 96% of the patients via the pterional transsylvian approach described previously. 65, 67 The ipsilateral optic nerve is usually displaced in a medial direction and hidden behind the tumor, which enlarges the opticocarotid window. The nerve normally cannot be identified at the beginning of the preparation, and in some cases it was helpful to dissect the contralateral unimpaired optic nerve first after partial resection of the tumor. The compressed ipsilateral optic nerve was thereafter identified by tracking the chiasm, allowing safe decompression of the nerve. It was often possible to release engulfed vessels by developing a dissection plane even in the absence of a continuous arachnoid membrane by using a distal to proximal microsurgical dissection. Tumors extending across the frontobasal midline or encroaching between both optic nerves were resected via a unilateral subfrontal route by extending the craniotomy anteriorly in the frontobasal dimension. Tumors extending into the optic canal were encountered in 16 patients (15%), and they were removed after unroofing of the optic canal except in 2 patients in whom small tumor tongues could carefully be pulled out (Fig. 2) . Resection of the falciform ligament and unroofing of the optic canal was also performed in 7 patients (6.6%) to relieve a squeezed optic nerve to avoid further traumatization. A hyperostosis mainly affecting the ACP and adjacent lesser sphenoid wing was noted in 26 patients (25%) on preoperative bone-window CT scanning (Fig. 3) . Drilling of the outer and middle portion of the sphenoid wing was performed before opening the dura. We prefer to perform an anterior clinoidectomy after opening the dura and after identification of both the optic nerve and ICA. Tumor infiltrating the superficial dural layer of the lateral wall of the CS was encountered intraoperatively in 14 patients (13%) and was peeled off and/or cauterized carefully with low current bipolar coagulation. Complete involvement of the CS was observed in 31 patients (29%), and the intracavernous tumor portion was left in situ. A frontoorbitozygomatic approach was used in 1 patient to resect hyperostotic bone of the middle cranial fossa and in another patient to remove tumor portions extending into the pterygopalatine fossa and into the lateral wall and roof of the orbit.
Patient Follow-Up
All patients underwent follow-up with clinical examinations and MR imaging studies 6 months and 1 year after surgery. Patients who underwent a radical tumor resection were reevaluated with clinical and radiological assessment at 1-or 2-year intervals based on each follow-up result. Patients with an intracavernous tumor remnant were scheduled for serial clinical and MR imaging follow-up examinations at yearly intervals. If clinical deterioration or radiological progression of the tumor was evident we proceeded either with reoperation and/or radiotherapy.
Results
Clinical Data
The main symptoms of the 84 female and 22 male pa- (1) . Lateral spread along the sphenoid ridge in 15% (2) . Complete involvement of the CS in 29% and of its lateral wall in 13% of the cases. Tumor spread along the petroclival ligament in 27% and extension to the superior orbital fissure in 9% of the patients (3). Growth into the optic canal in 15% of patients (4).
tients (mean age 56 years, range 13-76 years) were deterioration of vision in 57 (53.8%), headache in 30 (28.3%), and seizures in 17 (16.0%) patients (Table 1 ). The mean duration of the presenting symptoms prior to hospital admission was 20 months, with a wide range of 2 weeks-120 months. It is notable that despite gross involvement of the CS by tumor in 29% of the cases, patients rarely complained of dysfunction of ocular motor nerves such as double vision, which was reported preoperatively by only 4 patients (3.8%). On clinical examination, a monocular impairment of visual acuity was noted in 40 (37.7%) and a binocular impairment in 12 (11.3%) patients. Reduced vision in the contralateral eye was mainly caused by papilledema and was noted in 10 patients (9.4%); 11 patients (10.4%) had lost vision in 1 eye. Only 1 patient (1.4%) complained of a visual field deficit. However, on computed perimetric examination, a visual field cut was detected in 27 patients (25.5%). A deficit of CNs III-VI was present in 25 patients (23.6%), predominantly consisting of a third nerve palsy in 16 (15.1%) of these cases (Table 1) .
Radiological Investigations
Gross involvement of the CS by tumor displayed on MR images correlated well with intraoperative findings (27 vs 29%). There was, however, an underestimation of tumor infiltrating the lateral sinus wall. This infiltration was assumed radiologically in 9 patients (8.5%), but it was found to be present in 14 (13.2%) at surgery. Encasement of the ICA and/or its branches by tumor was noted on MR images in 50 patients (47.2%), and MR or catheter angiography revealed narrowing of the ICA vessel lumen in 12 cases (11.3%). In addition to hyperostosis of the ACP and adjacent sphenoid wing in 23 patients (21.7%), high-resolution bone-window CT scanning demonstrated hyperostosis of the roof and lateral wall of the orbit, planum sphenoidale, and sphenoid sinus wall in 1 case each. The mean maximal diameter of the lesions on preoperative MR imaging was 3.8 cm (range 1-8 cm). The main vascular supply to the tumors as assessed on preoperative angiography was via vessels originating from the ICA, usually branches of the meningohypophysial trunk (Fig.  4) . Preoperative superselective embolization of the MMA had to be abandoned in one patient in whom the ophthalmic artery originated from the MMA and in another patient with significant staining of retinal vessels on MMA contrast injection. One patient experienced a transient paresis of the arm and a motor aphasia and another patient had a temporary palsy of the abducent nerve immediately after embolization. Both patients recovered completely some days after the procedure. Preoperative embolization has been abandoned in recent years because it is no longer considered a beneficial preoperative adjunct. 
Surgical Considerations
The ICA was completely encased by the tumor in 51 patients (48.1%); however, an arachnoid dissection plane was usually present and facilitated complete removal of tumor portions adjoining the vessel. The tumor tightly adhered to the vessel adventitia in 11 patients (10.4%), to the ICA in 5, to the M 1 and M 2 segments of the MCA in 3, to the A 1 portion of the anterior cerebral artery in 1, and to all 3 vessels in 2 patients (Table 2 ). This operative finding had an impact on postoperative ischemic complications (see below). The tumor grossly dislocated and compressed the optic nerve in 79 patients (74.5%). It completely encased the optic nerve in 17 patients (16.0%), and vision had already been lost in the corresponding eye in 11 of these patients for a mean period of 2.5 years (range 1-6 years) prior to presentation. Vision did not improve in any case in which there was complete optic nerve encasement, and further deterioration in visual acuity was experienced by 2 patients. During surgery, the dural lining at the optic foramen was typically thickened and well vascularized because of tumor infiltration. It was often difficult to define the optic nerve in this fibrous tissue mass and to dissect it safely. The oculomotor nerve was grossly dislocated by the tumor in 21 patients (19.8%) but separated from it by arachnoid. Complete encasement of CN III was present in 9 patients (8.5%), usually at its point of entry at the superior CS wall. This finding was correlated with a new or aggravated permanent oculomotor nerve palsy after surgery (see below).
The extent of tumor resection according to the Simpson scale 62 was Grade I in 5 patients (4.7%), Grade II in 57 (53.8%), Grade III in 38 (35.8%), and Grade IV in 6 (5.7%). Tumor remnants were left in the CS in 31 patients, along the petroclival ligament in 4, adherent to the ICA or its branches in 3, around the optic nerve in 2, infiltrating the superior orbital fissure in 3 patients, and intrasellar in 1 patient.
Postoperative Complications
The main complications in this series were related to ophthalmological function (discussed below). A transient motor aphasia was encountered after a left-sided transsylvian approach in 8 patients (7.5%). A new postoperative hemiparesis completely resolved in 4 patients but persisted in 3. In 2 of the latter patients, the M 1 segment of the MCA was tightly adherent to the tumor, and hemiparesis probably resulted from injury to lenticulostriate perforating vessels during radical tumor removal. The third patient experienced infarction of the MCA presumably as a result of vasospasm after extensive manipulation of this vessel during tumor resection. A CSF leak was successfully treated by lumbar drainage in 4 patients. No patient required a shunt during the early postoperative period; however, a ventriculoperitoneal shunt had to be inserted for hydrocephalus developing as a result of tumor progression in 3 patients after a mean period of 3.5 years (range 3-4 years) postsurgery. There were 2 deaths related to surgery accounting for a surgical mortality rate of 1.9%. One patient developed an acute subdural hematoma contralateral to the surgical site during tumor removal. Immediate evacuation of the hematoma was performed; nonetheless, the patient died 3 days after surgery of global brain edema. The other patient developed infarction of the MCA after removal of a large (7.5-cm) meningioma. Although an immediate decompressive craniectomy was performed, subsequent CT scans revealed progression of the ischemic lesions in both hemispheres resembling delayed ischemia after subarachnoid hemorrhage. The patient died on the 8th postoperative day of global brain edema. Overall, the permanent postoperative morbidity, including deterioration of ophthalmological function, was 17% (Table 3) .
Ophthalmological Outcome
Preoperative and postoperative deficits of visual acuity, visual fields, and CNs subserving extraocular muscle function are displayed in Table 4 . Of 52 patients with impaired visual acuity on preoperative examination, the conditions in 21 (40.4%) improved and those of 7 (13.5%) deteriorated after surgery. The conditions in 24 patients (46.2%) remained unchanged, including those in 11 patients with a unilateral visual loss at presentation. No patient with normal preoperative vision experienced deterioration in his or her condition after surgery. However, a secondary deterioration of visual acuity due to tumor progression was observed in 8 (8.4%) of 95 patients with long-term follow-up, including 3 patients who experienced initial improvement. Visual decline occurred after a mean of 4.3 years (range 2-8 years) after the first surgery. In regard to visual field deficits, improvement was noted in 15 patients (55.6%), deterioration in 4 (14.8%), and no change in 8 (29.6%). A secondary deterioration due to tumor progression was observed in 9 patients (9.5%) after a mean postoperative period of 5.6 years (range 2.5-11.5 years).
A complete oculomotor nerve palsy that had been present preoperatively in 4 patients had not improved after surgery. This was also the case in 3 patients with a preexisting complete CN VI palsy. Complete CN lesions were caused by tumor infiltration of the CS. In the 12 patients who had a partial deficit of the oculomotor nerve, only ptosis improved in 4 of 8 patients. Double vision and/or mydriasis in 4 patients was not affected by surgery. A transient postoperative oculomotor nerve palsy was encountered in 13 pa- (48) 49 (46) 37 (35) 79 (75) 21 (20) 31 (29) encasement 51 (48) 11 (10) 8 (8) 17 (16) 9 (9) 0 adherence † 7 (7) 5 (5) 3 (3) 15 (14) 3 ( tients (12.5%) but recovered in all within 6 months. In these patients, the entry zone of the CN III into the roof of the CS was involved by en plaque extension of the tumor, which had been removed or coagulated. Eight patients (7.7%) experienced a new and permanent CN III palsy, which was complete in 5 and partial in 3. The oculomotor nerve was encased by tumor in 6 of these patients and could not be preserved in 4. Late development of an oculomotor nerve palsy due to tumor progression after a mean period of 3.9 years (range 2.5-5 years) after surgery was observed in 6 patients and progressed to ophthalmoplegia in 4.
Patient Follow-Up
Follow-up data including results of serial clinical and MR imaging examinations were available for assessment in 95 patients. The mean follow-up period was 6.9 years (range 1.5-18 years). The mean KPS score 23 improved from 82 (range 70-100) before surgery to 86 (range 40-100) after surgery. Fifty-five patients (57.9%) regained full daily activity (KPS Score 90-100). Thirty-five patients (36.8%) were independent but had neurological deficits, mainly a moderate to severe monocular visual deficit and/or a CN III palsy (KPS Score 70-80). Five patients required permanent assistance as a result of postoperative hemiparesis and/or mental deficits (KPS Score 40-60). We observed a secondary deterioration in functional neurological status as reflected by a decline in KPS score in 13 patients (13.7%) due to tumor recurrence or progression after a mean postoperative interval of 4.5 years (range 2-13 years). Neurological decline in these patients was primarily caused by progressive visual impairment in 1 eye in 8 patients and a CN III palsy in 6. In addition, 2 patients were rendered dependent due to mental deterioration.
Tumor Recurrence and Progression
A true tumor recurrence, defined as regrowth after complete initial tumor resection confirmed by postoperative MR imaging, was observed on follow-up MR imaging in 10 patients (10.5%). Two of these patients underwent a Simpson Grade I and 8 a Grade II tumor resection. Recurrences occurred after a mean postoperative interval of 4.8 years (range 2-8 years), and 3 recurrent meningiomas had displayed a high proliferation index or malignant features on histological examination after the initial resection. Radiological tumor recurrence paralleled clinical deterioration in 8 patients. All but 3 of these patients underwent a second surgery, and adjuvant radiotherapy was administered in 3 cases (fractionated radiotherapy in 2 and GKS in 1). The latter patient experienced a transient CN III palsy after irradiation of a tumor remnant in the CS. One asymptomatic and currently nonprogressive en plaque tumor regrowth along the planum sphenoidale is being followed up by observation.
Of 36 patients with a known residual tumor, 14 (38.9%) demonstrated tumor progression on MR imaging after a mean postoperative period of 4.8 years (range 2-7.5 years). This included 4 patients who had received adjuvant radiotherapy after their first surgery (GKS and fractionated radiotherapy in 2 each). The residual tumor was located in the CS in all patients and in addition at the superior orbital fissure in 2 cases. Eight patients experienced concurrent clinical deterioration with radiological progression. Nine patients underwent a second surgery, 3 of whom also received postoperative EBRT. Five patients underwent radiotherapy alone (GKS in 3 and EBRT in 2). There was no clinical or radiological progression of residual tumor grossly infiltrating the CS in 15 patients who were followed by observation alone for a period of 2-11 years (mean 4.7 years).
Histological Investigation
The meningioma was of the meningothelial subtype in 64 patients, fibroblastic in 21, transitional in 12, secretory in 3, and psammomatous in 2 patients. It was classified as atypical (WHO Grade II) in 2 patients and malignant (WHO Grade III) in 1. Two patients with benign histological subtypes but high proliferation index on Ki 67 staining experienced a recurrence 4 years after complete resection. Benign histological subtypes had no impact on the extent of tumor resection or clinical outcome. One patient with a rhabdoid meningioma (WHO Grade III) underwent adjuvant radiotherapy (60 Gy) but experienced tumor recurrence 2 years after surgery. Reoperation was planned, but the patient was lost to follow-up.
Discussion
Classification of Meningiomas
Meningiomas of the inner third of the sphenoid wing 6 who named them deep, clinoidal, or sphenocavernous meningiomas en masse. According to these investigators, clinoidal meningiomas originated from the dura of the CS, ACP, and inner part of the sphenoidal wings, a definition adopted in the present paper and in previous publications. 4 The term "sphenocavernous" as originally proposed by Clovis Vincent may be misleading because it denotes invasion of the CS, which is not always the case in ACP meningiomas. Later investigators proposed classifying these tumors according to their direction of growth, 50 the presence or absence of an interfacing arachnoid membrane between the tumor and the ICA, 2 or according to whether there was involvement of the CS. 41, 50 The most widely accepted classification system of ACP meningiomas was proposed by Al-Mefty 2 and identified the following 3 tumor groups: Group I tumors originate below the anterior clinoid process and proximal to the entrance of the ICA into the carotid cistern. Consequently, due to the absence of an intervening arachnoid membrane, the tumor is firmly attached to the adventitia of the carotid artery and cannot be completely removed. Group II tumors originate above the segment of the carotid invested in the carotid cistern; thus an arachnoid dissection plane facilitates total tumor removal. Group III meningiomas originate at the optic foramen and extend into the optic canal. Controversy exists regarding Group III tumors, which have been considered optic nerve sheath or optic foramen meningiomas by other investigators. 41, 64 However, we encountered 4 meningiomas (3.8%) in this series that originated in the ACP and extended into the medial aspect of the optic canal, exerting compression on the optic nerve. All 10 tumors encountered in the present series with firm attachment to the adventitia of the ICA or its branches (Group I tumors according to the Al-Mefty classification 2 ) were huge lesions with multiple areas of dural attachment, including the planum sphenoidale and middle cranial fossa. We were not able to identify a site of origin below the ACP in our retrospective analysis, a difficulty that has been expressed by previous investigators.
47
Presence of an arachnoid dissection plane is an intraoperative finding that cannot be anticipated from preoperative neuroimaging. Nonetheless, firm adherence of the tumor to the ICA and its branches as well as to the optic nerve had a direct impact on functional outcome and the rate of neurovascular complications encountered in this and previous reports. 6, 47 As pointed out by other investigators, invasion of the CS by meningioma is the most important parameter determining the rate of tumor recurrence and long-term outcome of the patient. 6, 41 Classification of ACP meningiomas according to involvement of the CS therefore seems reasonable, particularly as this feature can be predicted by the surgeon from preoperative contrast-enhanced MR imaging.
Clinical Aspects
Patients harboring an ACP meningioma usually present with unilateral visual complaints. In previous series, ophthalmological examination revealed decreased visual acuity in 39-92% of patients. 1, 4, 19, 41, 47, 50, 64 Impaired vision was found in 49% of our patients. The rate of visual field deficits as detected by computed perimetry was 26% in this series. This clinical sign was rarely investigated in previous series and was reported to be present in 19 24 and 53% 64 of the patients in 2 former studies. The clinical presentation of patients harboring ACP meningiomas was similar to patients with tuberculum sellae meningiomas in whom an impaired visual acuity and visual field deficits were found in 79 and 64%, respectively.
5 However, other neurological symptoms and signs, such as seizures, ocular motor nerve palsies, and hemiparesis were either absent or rarely encountered in patients with tuberculum sellae meningiomas. 5 Patients harboring meningiomas confined to the CS or originating within the CS usually present with deficits of the ocular motor and trigeminal nerves. 8, 26, 51 The rate of ocular motor and trigeminal nerve deficits in these patients ranges between 62 and 82% 8,26,55 and 16 and 50%, 8, 26 respectively. In contrast, patients with ACP meningiomas rarely present with an ocular motor nerve palsy and if present it usually points to CS invasion. 19, 41 Notably, only 4% of our patients complained of double vision at presentation; the rate of diplopia has ranged between 0 and 21% in earlier series. 41, 47, 50, 64, 65 This low figure at presentation must be considered when surgical removal of an intracavernous tumor portion is planned. Invading meningioma of the sphenoid wing en plaque should clearly be distinguished from ACP meningiomas because of their different clinical presentation and surgical particularities. The most prominent clinical feature in these patients is unilateral exophthalmos, which is present in 49-89% of the patients. 6, 46, 49, 53, 54 Proptosis has been reported in 12-25% of the patients in clinical series, including the present one.
41,47,50
Surgical Considerations
The pterional-transsylvian approach has been successfully used by several surgeons for resection of ACP meningiomas irrespective of the size of the tumor. 15, 41, 43, 47, 50, 65, 67 This approach offers several advantages. It permits a direct approach to the dural attachment of the tumor along the sphenoid ridge and thereby allows for early devascularization. Wide opening of the sylvian fissure improves surgical access and optimizes visualization of all critical neurovascular structures (the MCA, anterior cerebral artery, ICA, and anterior optic pathways). Intradural or extradural removal of hyperostotic bone of the sphenoid wing including the ACP can be performed. Good relaxation of the brain is achieved by opening the basal cisterns and releasing the CSF. This maneuver avoids application of self-retaining spatulas in many cases. We did not encounter tumor extensions along the clivus in this series, which would have posed a limitation of the pterional approach. Extension of ACP meningiomas into the optic canal has been reported in 0-33% of the cases and was encountered in 15% of our patients. 1, 6, 31, 47 Unroofing of the optic canal was usually performed in these patients as well as in cases in which the optic nerve was squeezed against the falciform ligament to prevent further traumatization. Some investigators advocate routine anterior clinoidectomy and have recommended early unroofing of the optic canal 19,31,32 and opening of the optic nerve sheath to minimize surgical trauma to the optic nerve.
31,32
We removed the ACP in patients displaying hyperostosis on preoperative high-resolution bone-window CT scans (22% of patients). Hyperostosis of the sphenoid wing was present in 21-42% of patients in previous publications, and removal of these bone parts is recommended because histopathological examination has demonstrated a high incidence of tumor infiltration. 6, 19, 41, 47 However, to date there is no clear evidence that resection of bone lowers the tumor recurrence rate in the long term. Furthermore, a recent investigation has found that visual recovery was less favorable in patients who had undergone bone removal. 41 One must remember that an aerated ACP may be a potential site of CSF leakage through communication with the sphenoid sinus. 68 We have preferred to unroof the optic canal and perform an anterior clinoidectomy from the intradural route after identifying the optic nerve and ICA. This was considered safer than a pure extradural bone removal by previous investigators. 36, 41 Extradural resection of the hyperostotic ACP has resulted in optic nerve injury 68 and may further entail some risk of vascular injury in the rare case of bone bridges to the middle and/or posterior clinoid processes. Some investigators have advocated extensive orbitocranial approaches with routine unroofing of the foramina rotundum and ovale as well as performing a posterolateral orbitotomy. 1, 12, 19, 32 In our experience, these extensive bone resections may be required in hyperostosing meningiomas en plaque of the sphenoid bone but are only exceptionally required in ACP meningiomas.
In a recent communication, Lee et al. 32 advocated early exposure of the ICA for proximal control and further dissection of the tumor directed toward the bifurcation of the ICA. Large tumors often extend widely into the sylvian fissure and thereby occlude the route to the carotid cistern and ICA. In our view, it may be safer in these cases to direct tumor dissection from the distal MCA toward the carotid bifurcation. Encasement of the ICA trunk and its branches was encountered in 48% of our patients and has been reported in 20-55% of the cases in recent microsurgical series. 1, 2, 19, 47 It was often possible to dissect the vascular structures out of tumors by using microsurgical techniques even in the absence of a continuous arachnoid plane. However, this procedure entails some risk of inducing vasospasm of the vessels with subsequent delayed neurological sequelae. This complication was encountered in 2 of our patients, resulting in death in one and severe neurological compromise with hemiplegia in the other. Surgical death due to severe refractive vasospasm has been reported by several investigators; 3, 14, 47 hence, it may be preferable to leave a tumor tuft along the vessel in these cases.
Ophthalmological Outcome
Visual Acuity. Surgical results for postoperative visual acuity and ocular motor nerve function after resection of ACP meningiomas are difficult to determine from previous publications. 2, 11, 13, 25, 32, 64 In the present series, visual acuity, improved in 37%, remained unchanged in 51%, and deteriorated in 12% of the patients early after surgery. There was no improvement in patients who had preoperative visual loss, a finding consistent with previous reports. 41, 67 At our institution, outcome of visual acuity in patients harboring an ACP meningioma was worse than that in 62 patients treated microsurgically for a tuberculum sellae meningioma in our institution.
5 Al-Mefty 2 ascribed this difference in visual recovery in both entities to ischemia rather than mere optic nerve compression as a main mechanism of visual compromise in clinoidal meningiomas. The relationship of the tumor to the optic nerve had an impact on visual outcome in our series. The optic nerve was completely encased and devoid of an arachnoid dissection plane in 16% of our patients, and visual outcome was uniformly unfavorable in these cases. Al-Mefty reported complete encasement of the optic nerves by tumor in 29% of his patients. An arachnoid plane was present in all his cases, but functional outcome in this patient group was not detailed. As recommended by Al-Mefty and supported by our intraoperative findings, it is advisable to direct dissection from the chiasmal site, as engulfment of the optic nerve is most prominent at the optic foramen.
The issue of long-term visual results was usually not addressed in previous publications. 2, 12, 19, 32, 43, 47, 65 A secondary deterioration in visual acuity due to tumor progression was observed in 8% of our patients after a mean period of 4.3 years following surgery. Risi et al. 50 reported improved vision in 32%, stable vision in 36%, and worsening vision in 32% of their patients after surgery. Further deterioration 1-3 years after the first surgery was observed in 21% of their patients due to tumor progression after partial resections. Goel and coworkers 19 observed improvement of vision in only 23% and deterioration in 5% of their patients. In contrast, Tobias et al. 64 reported an improvement of vision in 71%, unchanged vision in 29%, and no worsening in their series of 26 patients. They observed no secondary deterioration after a mean follow-up period of 42.3 months. Nakamura et al. 41 observed improvement in vision in 49%, no change in 47%, and immediate postoperative deterioration in 4% of patients. Vision deteriorated in 10% of their patients with tumor infiltration of the CS after a mean follow-up period of 6.6 years. 41 Ocular Motor Function. Of the 3 ocular motor nerves, persistent diplopia due to a CN III palsy is the most troublesome for the patient because of unsatisfactory results of corrective measures such as prism treatment and strabismic surgery. 20 A persistent postoperative CN III palsy was observed in 8% of the patients. Diplopia did not develop in 3 of 8 patients because they already had preoperative loss of vision in the corresponding eye. Double vision posed a permanent problem in 3 patients (2.8%). The incidence of permanent oculomotor nerve deficit after resection of an ACP meningioma has been reported to be 0, 12,64,65 4, 2 and 15%. 46 Detailed long-term follow-up data on oculomotor nerve function were usually not provided in previous reports. 2, 19, 41, 43, 47, 50, 64 In this series, 6% of patients exhibited worsening of oculomotor nerve function due to tumor progression after a mean period of 4.5 years (range 2-6 years) after their first surgery. There were no new or aggravated deficits in CN IV and VI function, probably as a result of our conservative at-titude toward tumor involvement of the CS. Furthermore, deficits of the trochlear and abducent nerves were not encountered during the follow-up period in the present series. Previous publications have reported permanent new deficit in ocular nerve function in 4, 2 11, 14 and 18% 44 of the patients after surgical entry of the CS for meningioma resection.
Complications and Outcome
From a surgical perspective, functional outcome after resection of an ACP meningioma is mainly determined by 3 factors: relationship of the tumor to the ICA and its branches; relationship to the optic apparatus; and tumor extension into the CS. The rate of permanent morbidity in our series was 17% and was reported to range between 0 and 32% in recent microsurgical series. 2, 12, 24, 47, 64, 65 Apart from ophthalmological deficits, the most severe neurological sequela in our series resulted from cerebral ischemia, which displayed 2 pathophysiological patterns. Ischemia either resulted from direct injury to perforating arteries during aggressive removal of meningiomas adherent to the vessel adventitia, or it was secondary to vasospasm after extensive manipulation of the vessels, which resulted in progressive delayed neurological deficits and eventual death in 1 patient. Careful manipulation of involved vessels with particular attention paid to perforating arteries and leaving a tuft of tumor attached to the vessel wall may avoid this complication.
The rate of surgical mortality in the early microsurgical era was as high as 43%;
6 however, most recent publications including the present series have reported a mortality rate ranging between 0 and 15%. 1, 2, 12, 19, 41, 47, 50, 52, 64, 65 Overall improvement after surgery was seen in 49% of the patients, 38% remained stable, and early worsening of the preoperative condition was encountered in 13% of our patients. Previous publications reported an overall amelioration of preoperative condition in 52 47 and 63% 1 of the patients and a deterioration rate ranging between 8 and 29% after surgery. 1, 47, 50 Neurological outcome on long-term follow-up was usually not considered in earlier publications.
2,12,19,64 Risi et al. 50 reported a poor outcome in 18% of their patients mainly due to tumor progression after a short mean follow-up of 23 months after surgery. Clinical deterioration was presumed to be secondary to postoperative radiotherapy in 6% of their cases. AbdelAziz and coworkers 1 report excellent results in their survey of 38 patients, with a persistent morbidity in 16% and a KPS score > 90 in 89% of their cases 1 year after surgery. Bonnal et al. 6 reported the natural history of 5 patients who did not undergo surgery because of advanced age. All were alive, some 10 years after diagnosis, all had major oculomotor signs, and most had unilateral visual loss. In the current series, 95 patients had a long-term follow-up for a mean period of 6.9 years. With our conservative treatment strategy we have observed deterioration in neurological condition due to tumor progression in 14% of the patients. Vision loss occurred in 3% of the patients, and ophthalmoplegia had developed in 4% of the cases. Two patients (2%) were rendered dependent due to mental deterioration 4 years after surgery. Both had progressive tumors, and 1 underwent EBRT (50 Gy).
Resection Rate
Total removal of an ACP meningioma is often limited due to its intimate relationship to the ICA and optic nerve as well as tumor invasion of the CS. 1, 6, 47, 50, 64 Complete tumor resection rates were reported in 0, 6 55, 47 67, 12 70, 19 and 77% 64 of the patients in microsurgical series (Table 5) . A total tumor resection rate, defined as a Simpson Grade I or II resection, was achieved in 58% of our patients. The main reason for a subtotal tumor resection in this and previous series was invasion of the CS. Complete infiltration of the CS by meningioma shows a wide range in unbiased microsurgical series and was observed in 0, 19 23, 64 38, 2 39, 47 44, 50 and 64% 41 of the patients. It was encountered in 29% of our cases. In attempting to achieve a more radical tumor resection with a concomitant decrease in tumor recurrence rate, some authors have advocated removal of the cavernous portion of the tumor, although their recommendations vary regarding radicality of the procedure to accomplish this goal. 2, 14, 44, 56, 57 In a histopathological study, Kotapka et al., 27 found infiltration of the cavernous part of the ICA by tumor up to the tunica muscularis in 42% of their specimens. These findings were confirmed in a subsequent histopathological study. 60 Consequently, De Jesús and coworkers 13 performed radical removal of the CS tumor portion including resection and grafting of the intracavernous ICA in a series of 119 patients with meningiomas involving the CS. They achieved total tumor removal in 61% of their patients. After a relatively short mean follow-up period of 34 months, they observed a recurrence in 10% of the patients after radical removal and progression of residual tumor in 15% of the patients after subtotal resection. A detailed clinical outcome after surgery, particularly the ophthalmological results, was not provided in their study. DeMonte at al.
14 advocated removal of the intracavernous tumor without resection of the ICA. These authors argued that resection of the cavernous ICA does not enhance oncological cure because microscopic tumor deposits may remain along the CNs. They achieved total resection in 76% of their patients. After a mean follow-up period of 45 months, they observed tumor recurrence after total resection in 11% and tumor regrowth after subtotal removal in 20% of their patients. They reported improvement of preoperative CN neuropathy in 14% of their patients and observed a new CN palsy in 15% of their cases.
14 Improvement in preoperative ocular motor and trigeminal nerve deficits has been reported by other authors after resection of meningiomas involving the CS with rates of 0, 59 14, 14 21, 44 and up to 50%. 26 However, it is unclear whether these improvements were sustained on long-term follow-up, as this issue was not addressed in these studies. Tumor growth along the dural sheaths of CNs traversing the CS was observed on several occasions, 26, 64, 66 and frank infiltration of the perineurium of these nerves was demonstrated on histological examination. 29, 58 Other investigators, therefore, have concluded that a total resection of meningiomas invading the CS is not likely to be achieved without sacrifice of the neurovascular content of the CS. 26, 34, 44, 58, 66 In a study of 39 patients with meningiomas involving the CS, O'Sullivan and coworkers 44 achieved a total tumor resection in 21% of the cases. Although surgical mortality was 0% in their series, morbidity for CNs subserving extraocular motion function was 18%. Furthermore, the tumor recurrence rate was 25% even after total resection after a short mean follow-up period of 24 months. These authors concluded that total excision is rarely achieved in holocavernous meningiomas and that CN morbidity is considerable. Puzzilli and coworkers 47 performed a radical removal of the intracavernous tumor portion in 54% of the cases with CS involvement. The mortality and permanent morbidity rates in this group were 14 and 43%, respectively. It is noteworthy that tumor infiltration of the adventitia of the intracavernous ICA may weaken the vessel wall through interfering with its blood supply by neoplastic occlusion of the vasa vasorum. 60 Laceration of the ICA and pseudoaneurysm formation requiring surgical repair have complicated resection of the intracavernous tumor portion on several occasions. 13, 26, 27, 66 Tumor Recurrence and Progression Mathiesen et al. 37 investigated the recurrence rate of cranial base meningiomas in a long-term study and found the highest rate of recurrence in medial sphenoid wing/ clinoidal meningiomas. Of the patients harboring tumors in this location, 51% died during follow-up as a result of their tumors, and the 10-year recurrence rate was calculated to be in the range of 60-100%. Similarly, in patients with ACP meningiomas, Mirimanoff et al. 39 reported recurrence and progression rates of 34 and 54% at 5 and 10 years, respectively.
To accurately evaluate the results of surgery, it is important to distinguish between true tumor recurrence after total tumor resection and tumor progression after subtotal removal. Total tumor removal should be confirmed by postoperative contrast-enhanced MR imaging. The recurrence rate after total tumor resection was reported to be 0, 64 2, 19 12, 1 20, 41 25, 6 and 26% 47 in recent microsurgical series. However, recurrence rates reported are difficult to compare because the series differ considerably in the number of tumors invading the CS, the number of recurrences that are surgically treated, and particularly the time period of follow-up after surgery. Nakamura et al. 41 found a recurrence rate of 7.7% in clinoidal meningiomas without CS involvement in contrast to a recurrence rate of 27.5% in tumors that invaded the CS. Considering the wide spectrum of biological behavior and growth rates displayed, even in benign meningiomas, it is important to assess a long period after surgery. In a long-term followup study, Kallio et al. 22 reported that the median time of appearance of recurrence after resection of an intracranial meningioma was 7.5 years. These authors concluded that the postoperative observation period should be at least 5 years to reliably state the recurrence rate in meningiomas after surgery. Most published microsurgical series had a relatively short mean follow-up period ranging between 23 and 57 months. 2, 11, 13, 19, 47, 50, 64, 65 Tumor recurrences and tumor progression in our series were encountered after a mean postoperative interval of 58 months (range 24-96 months). After a mean follow-up time of 83 months, we have observed tumor recurrence in 10% and progression in 39% of patients with known residual tumor on followup MR imaging. Studies advocating radical resection of meningiomas involving the CS have reported a tumor recurrence rate of 0-11% after radical tumor resection and a tumor progression rate of 8-20% after subtotal resection. 2, 13, 14 However, it is not yet clear whether radical treatment strategies will be translated into an overall lower recurrence rate on longer follow-up.
Role of Radiotherapy
Several series published in recent years have documented the efficiency of radiotherapy in the treatment of meningiomas involving the CS. To obtain a high tumor control rate it is important to cover the entire tumor volume with an adequately high radiation dosage. 61 This prerequisite may exceed the radiation dose tolerance of the optic nerve, which was reported to be 10 Gy in a dose-response study conducted by Leber and coworkers. 30 In contrast, nerves subserving ocular motion have a higher dose tolerance. 30, 33, 40 Permanent procedurerelated complications after radiosurgery are rare and have been reported in 0-10.5% of patients. 21, 33, 35, 38, 40, 42, 51, 61 They mainly consist of delayed optic nerve neuropathy, trigeminal nerve dysfunction, cognitive deficits, and seizures. All patients with known residual tumors in our series had involvement of the CS. Tumor control was achieved in 75% of the patients after adjuvant radiotherapy with a mean follow-up of 5.1 years (range 2-11 years) in this patient subgroup. The tumor was progressive in 1 patient 4 years after GKS and in another patient 6 years after fractionated radiotherapy. Both tumors progressed within the former radiation portal. Most patients with residual tumor (64%) were primarily followed by observation and periodic MR imaging. The rationale for this management strategy was 3-fold as follows: 1) The biological behavior of the tumor cannot be predicted, and long-term observation periods in patients without clinical and radiological progression were observed by us and are known from the literature. 24, 43, 63 2) If reoperation after radiotherapy is deemed necessary, it is associated with a much higher complication rate. 56 3) Before radiosurgery became available, fractionated radiotherapy, once used, was definite and could not be repeated if required thereafter. In patients primarily observed, the tumor remnant was stable in 43% after a mean follow-up of 4.3 years (range 2-7.5 years) and was progressive in 57% after a mean period of 3.5 years (range 6 months-7 years). We think that there is no disadvantage in deferring radiotherapy for the patient with intracavernous residual tumor until progression of the lesion becomes evident on serial MR imaging; however, it must be acknowledged that most of these tumors will ultimately progress within a few years. Therefore, our current treatment strategy is to resect the extracavernous tumor portion as radically as is compatible with a good functional outcome and follow an intracavernous tumor portion with periodic clinical and MR imaging examinations. When progression is apparent, radiosurgery is instituted, as functional results after radiosurgery for meningiomas involving the CS have proved to be superior to those obtained after microsurgical resection. 28 However, failure to control meningioma remnants with radiotherapy was recognized in this and other series, and these cases pose serious therapeutic problems. 13 A recent study indicated that the growth pattern in progressive benign meningiomas after failed radiosurgery can be unusually aggressive. 9 Surgery in recurrent tumors should primarily focus on relieving the patient's symptoms and signs, usually optic nerve decompression, without aggressive attempts at radical removal with the risk of neurological compromise. The safety margin created surgically between the tumor remnant and the anterior visual pathways facilitates optimal radiation coverage of the tumor, which is required for longterm tumor control.
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Conclusions
We conducted a retrospective analysis of 106 patients treated microsurgically for an ACP meningioma. The treat ment strategy consisted of total removal of the extracavernous tumor portion, including hyperostotic bone as noted on the preoperative bone-window CT scan, via a pte rional approach. An intracavernous tumor portion, present in 29% of the patients, was left in situ. Postoperative morbidity was closely associated with tumor involvement of critical neurovascular structures (encasement and adhesion) as observed during surgery. We recommend leav ing an intracavernous tumor portion, if present, as it proved beneficial for the patient in regard to quality of life after surgery. To date, no long-term follow-up study has convincingly demonstrated the oncological benefit of radical resection of intracavernous tumor in terms of reduced recurrence rate. However, this procedure is associated with a high complication rate particularly in regard to ocular motor nerve palsies. Nonetheless, our conservative surgical strategy was associated with considerable tumor recurrence and progression rates of 10 and 38%, respectively, and with a concurrent clinical deterioration in 14% of the patients at long-term follow-up. In this regard, stereotactic radiosurgery offers a promising tool for long-term tumor control.
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